人类脓毒症期间单核细胞免疫表型分析显示抗原呈递受损:向非经典分化偏移及FCγRI受体上调
该研究纳入61例脓毒症患者和31名健康志愿者,在基线(D0,N=61)及治疗7天(D7,N=36)、14天(D14,N=22)采集样本,分析单核细胞表面受体表达及其与临床结局的关联。结果显示,与健康志愿者相比,脓毒症患者单核细胞CD86、HLA-DR、CD200R、CCR2、CXCR2和CD163表达降低,而PD-1、PD-L1、CD206、CD64和CD16表达上调。幸存者HLA-DR、CD64、PD-1和PD-L1表达水平高于非幸存者。随访中CD86、HLA-DR和CXCR2表达升高,而CD64和CD16几何平均荧光强度随时间下降。结论认为脓毒症患者单核细胞抗原呈递受损,同时炎症和吞噬活性可能增强,向M2表型分化的结果相互矛盾。
要点
- 脓毒症患者单核细胞HLA-DR和CD86表达低于健康志愿者,PD-1和PD-L1表达高于健康志愿者,提示抗原呈递受损。
- 幸存者单核细胞HLA-DR、CD64、PD-1和PD-L1表达水平高于非幸存者。
- 随访期间CD86、HLA-DR和CXCR2表达升高,CD64和CD16几何平均荧光强度随时间下降。
- 脓毒症患者单核细胞CD206表达升高而CD163表达降低,向M2表型分化的结果相互矛盾。
- 脓毒症患者单核细胞CD16表达升高,提示非经典单核细胞亚群增加。
适用人群与场景
- 脓毒症患者(61例)与健康志愿者(31名)对照,样本在基线(D0,N=61)、治疗7天(D7,N=36)和14天(D14,N=22)采集。
研究设计与关键结果
- 研究类型为观察性研究,纳入61例脓毒症患者和31名健康志愿者,在基线及治疗7天、14天采集样本进行单核细胞免疫表型分析。
- 与健康志愿者相比,脓毒症患者单核细胞CD86、HLA-DR、CD200R、CCR2、CXCR2和CD163表达降低。
- 与健康志愿者相比,脓毒症患者单核细胞PD-1、PD-L1、CD206、CD64和CD16表达上调。
- 幸存者单核细胞HLA-DR、CD64、PD-1和PD-L1表达水平高于非幸存者。
- 随访样本中CD86、HLA-DR和CXCR2表达升高,CD64和CD16几何平均荧光强度随时间下降。
- 脓毒症患者单核细胞CD206表达升高而CD163表达降低,向M2表型分化的结果相互矛盾;CD16表达升高提示非经典单核细胞亚群增加。
证据类型、等级与局限
- 证据类型:观察性研究(病例对照及随访),原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Monocytes and macrophages are pivotal in the host response to sepsis, recognizing the infecting microorganism and triggering an inflammatory response. These functions are, at least in part, modulated by the expression of cell surface receptors. We aimed to characterize the monocyte phenotype from septic patients during an ongoing sepsis process and its association with clinical outcomes. Sixty-one septic patients and 31 healthy volunteers (HVs) were enrolled in the study. Samples were obtained from patients at baseline (D0, N = 61), and after 7 (D7, N = 36) and 14 days of therapy (D14, N = 22). Monocytes from septic patients presented decreased expression of CD86, HLA-DR, CD200R, CCR2, CXCR2, and CD163 compared with HV monocytes. In contrast, the PD-1, PD-L1, CD206, CD64, and CD16 expression levels were upregulated in patients. HLA-DR, CD64, PD-1, and PD-L1 expression levels were higher in survivors than in nonsurvivors. Increased CD86, HLA-DR, and CXCR2 expression levels were observed in follow-up samples; in contrast, CD64 and CD16 GMFI decreased over time. In conclusion, monocytes from septic patients show antigen presentation impairment as characterized by decreased HLA-DR and costimulatory CD86 expression and increased PD-1 and PD-L1 expression. On the contrary, increased monocyte inflammatory and phagocytic activities may be inferred by the increased CD16 and CD64 expression. We found conflicting results regarding differentiation toward the M2 phenotype, with increased CD206 expression and decreased CD163 expression on monocytes from septic patients, whereas the subset of nonclassical monocytes was demonstrated by increased CD16.
参考来源
- Ferreira da Mota NV, Brunialti MKC, Santos SS, et al. Immunophenotyping of Monocytes During Human Sepsis Shows Impairment in Antigen Presentation: A Shift Toward Nonclassical Differentiation and Upregulation of FCγRi-Receptor. Shock. 2018. PMID: 29668526. doi:10.1097/SHK.0000000000001078
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。